Nunziatina L. Parrinello
Catania, 95123, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
FcγRIIIA Genotype in Plasma Cell Dyscrasias Is Associated with Clinical Progression, Bone Disease Extension and Immune Dysfunction.
Journal: Cancers
Published: February 20, 2026
Real-world single-center experience with pixantrone in DLBCL prior to its withdrawal: clinical outcomes and exploratory immunologic observations.
Journal: Annals of hematology
Published: January 12, 2026
Next Generation Flow and Next Generation Sequencing for Measurable Residual Disease Assessment in Multiple Myeloma Patients: A Real-Life Italian Multicenter Harmonization Experience.
Journal: Cancer medicine
Published: October 07, 2025
COVID-19 Vaccine Experience: Loss of Humoral Response Following Autologous Stem Cell Transplantation in Multiple Myeloma Patients and Positive Effect of Booster Dose.
Journal: Journal of clinical medicine
Published: May 14, 2025
BNT162b2 mRNA vaccination affects the gut microbiome composition of patients with follicular lymphoma and chronic lymphocytic leukemia.
Journal: Biomarker research
Published: September 19, 2024
In vivo Effects of Disease-modifying Therapies on Immunological Subsets in Patients with Relapsing-Remitting Multiple Sclerosis.
Journal: Current neuropharmacology
Published: September 15, 2024
IgG-k/IgG-λ Para-Osseous Plasmacytoma Relapsed as Soft-Tissue Plasmacytoma with IgA-k Immunophenotype: A Case Report and Review of the Literature on Related Biochemical Aspects.
Journal: Hematology reports
Published: March 16, 2024
Correction: Sigma-1 and Sigma-2 receptor ligands induce apoptosis and autophagy but have opposite effect on cell proliferation in uveal melanoma.
Journal: Oncotarget
Published: March 14, 2024
Multiple Myeloma in 2023 Ways: From Trials to Real Life.
Journal: Current oncology (Toronto, Ont.)
Published: September 30, 2023
High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability.
Journal: OncoTargets and therapy
Published: April 06, 2023
Potential clinical impact of T-cell lymphocyte kinetics monitoring in patients with B cell precursors acute lymphoblastic leukemia treated with blinatumomab: a single-center experience.
Journal: Frontiers in immunology
Published: March 28, 2023
Last Updated: 09/26/2026